Colangeli V - Search Results

Year	Number of Results
1987	1
1989	1
1990	1
1993	1
1996	2
1998	1
1999	3
2000	2
2001	2
2002	2
2003	3
2004	2
2005	4
2006	2
2007	1
2008	7
2009	5
2010	3
2011	6
2012	5
2013	4
2014	7
2015	7
2016	8
2017	9
2018	3
2019	7
2020	9
2021	5
2022	1
2023	2
2024	2

1

Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients.

Calza L, Colangeli V, Manfredi R, Bon I, Re MC, Viale P. Calza L, et al. Among authors: colangeli v. J Antimicrob Chemother. 2016 Jun;71(6):1451-65. doi: 10.1093/jac/dkv494. Epub 2016 Feb 3. J Antimicrob Chemother. 2016. PMID: 26846208 Review.

2

Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience.

Calza L, Colangeli V, Pensalfine G, Appolloni L, Vitale S, Bon I, Viale P. Calza L, et al. Among authors: colangeli v. Int J STD AIDS. 2023 Dec;34(14):1018-1023. doi: 10.1177/09564624231195084. Epub 2023 Aug 11. Int J STD AIDS. 2023. PMID: 37565832

3

Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain.

Calza L, Giglia M, Colangeli V, Bon I, Vitale S, Viale P. Calza L, et al. Among authors: colangeli v. HIV Med. 2024 Aug;25(8):919-926. doi: 10.1111/hiv.13644. Epub 2024 Apr 3. HIV Med. 2024. PMID: 38570897

4

Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir.

Calza L, Borderi M, Colangeli V, Miani T, Nuti B, Bon I, Lazzarotto T, Viale P. Calza L, et al. Among authors: colangeli v. AIDS. 2022 Jan 1;36(1):153-155. doi: 10.1097/QAD.0000000000003063. AIDS. 2022. PMID: 34873095 No abstract available.

5

Disseminated histoplasmosis with atypical cutaneous lesions in an Italian HIV-infected patient: another autochtonous case.

Calza L, Manfredi R, Donzelli C, Marinacci G, Colangeli V, Chiodo F. Calza L, et al. Among authors: colangeli v. HIV Med. 2003 Apr;4(2):145-8. doi: 10.1046/j.1468-1293.2003.00144.x. HIV Med. 2003. PMID: 12702136 Free article. Review.

6

COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection.

Calza L, Bon I, Borderi M, Colangeli V, Borioni A, Re MC, Viale P. Calza L, et al. Among authors: colangeli v. J Acquir Immune Defic Syndr. 2021 Jan 1;86(1):e15-e17. doi: 10.1097/QAI.0000000000002537. J Acquir Immune Defic Syndr. 2021. PMID: 33065583 Free PMC article. No abstract available.

7

COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy.

Calza L, Bon I, Tadolini M, Borderi M, Colangeli V, Badia L, Verucchi G, Rossini G, Vocale C, Gaibani P, Viale P, Attard L. Calza L, et al. Among authors: colangeli v. Infection. 2021 Apr;49(2):333-337. doi: 10.1007/s15010-020-01492-7. Epub 2020 Aug 3. Infection. 2021. PMID: 32748333 Free PMC article.

8

Short Communication: No Significant Changes in Weight and Body Fat Mass in Suppressed HIV-Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir.

Calza L, Borderi M, Colangeli V, Testi D, Amedeo A, Bon I, Re MC, Viale P. Calza L, et al. Among authors: colangeli v. AIDS Res Hum Retroviruses. 2021 Mar;37(3):204-206. doi: 10.1089/AID.2020.0117. Epub 2020 Nov 24. AIDS Res Hum Retroviruses. 2021. PMID: 33126811

9

No Significant Effect of COVID-19 on Immunological and Virological Parameters in Patients With HIV-1 Infection.

Calza L, Bon I, Borderi M, Colangeli V, Viale P. Calza L, et al. Among authors: colangeli v. J Acquir Immune Defic Syndr. 2020 Sep 1;85(1):e6-e8. doi: 10.1097/QAI.0000000000002427. J Acquir Immune Defic Syndr. 2020. PMID: 32568768 No abstract available.

10

The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study.

Rossetti B, Gagliardini R, Sterrantino G, Colangeli V, Latini A, Colafigli M, Vignale F, Rusconi S, Di Biagio A, Orofino G, Mezzaroma I, Vullo V, Francisci D, Mastroianni C, Trezzi M, Canovari B, Lamonica S, Ciccullo A, Borghetti A, DʼArminio Monforte A, Di Giambenedetto S, De Luca A; for GUSTA trial study group. Rossetti B, et al. Among authors: colangeli v. J Acquir Immune Defic Syndr. 2019 May 1;81(1):e17-e21. doi: 10.1097/QAI.0000000000001986. J Acquir Immune Defic Syndr. 2019. PMID: 30789452 Free PMC article. Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Results by year